ATE355288T1 - COMPOUNDS AND THERAPEUTIC METHODS - Google Patents

COMPOUNDS AND THERAPEUTIC METHODS

Info

Publication number
ATE355288T1
ATE355288T1 AT00926538T AT00926538T ATE355288T1 AT E355288 T1 ATE355288 T1 AT E355288T1 AT 00926538 T AT00926538 T AT 00926538T AT 00926538 T AT00926538 T AT 00926538T AT E355288 T1 ATE355288 T1 AT E355288T1
Authority
AT
Austria
Prior art keywords
compounds
therapeutic methods
treatment
diseases
methods
Prior art date
Application number
AT00926538T
Other languages
German (de)
Inventor
Rodney W Rickards
Geoffrey D Smith
Kiaran Kirk
Original Assignee
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ0373A external-priority patent/AUPQ037399A0/en
Priority claimed from AUPQ0506A external-priority patent/AUPQ050699A0/en
Application filed by Univ Australian filed Critical Univ Australian
Application granted granted Critical
Publication of ATE355288T1 publication Critical patent/ATE355288T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

The present invention relates to indolo[3,2-j]phenanthridine compounds and their use in the treatment of cancer and other diseases of humans and animals including parasitic diseases such as those of Apicomplexan origin, compositions containing said compounds and methods of treatment using them.</PTEXT>
AT00926538T 1999-05-14 2000-05-12 COMPOUNDS AND THERAPEUTIC METHODS ATE355288T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ0373A AUPQ037399A0 (en) 1999-05-14 1999-05-14 Novel compounds and therapeutic methods
AUPQ0506A AUPQ050699A0 (en) 1999-05-21 1999-05-21 Novel compounds and therapeutic methods-ii

Publications (1)

Publication Number Publication Date
ATE355288T1 true ATE355288T1 (en) 2006-03-15

Family

ID=25646057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00926538T ATE355288T1 (en) 1999-05-14 2000-05-12 COMPOUNDS AND THERAPEUTIC METHODS

Country Status (7)

Country Link
US (1) US6632822B1 (en)
EP (1) EP1178988B1 (en)
JP (1) JP2002544275A (en)
AT (1) ATE355288T1 (en)
CA (1) CA2372032A1 (en)
DE (1) DE60033649D1 (en)
WO (1) WO2000069856A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962023B2 (en) 2004-09-28 2015-02-24 Atrium Medical Corporation UV cured gel and method of making
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
WO2006036967A1 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
CA2764653C (en) 2009-06-10 2018-01-02 Chugai Seiyaku Kabushiki Kaisha Tetracyclic compounds
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en) 2010-07-16 2012-01-19 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
EP2606886B1 (en) 2010-08-20 2020-01-08 Chugai Seiyaku Kabushiki Kaisha Composition comprising tetracyclic compound
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CA3077553C (en) 2012-09-25 2022-08-02 Chugai Seiyaku Kabushiki Kaisha Ret inhibitor
AU2015250574B2 (en) 2014-04-25 2020-07-16 Chugai Seiyaku Kabushiki Kaisha Preparation containing tetracyclic compound at high dose
CA2946268A1 (en) 2014-04-25 2015-10-29 Chugai Seiyaku Kabushiki Kaisha Crystal of tetracyclic compound
TWI718102B (en) 2014-08-08 2021-02-11 日商中外製藥股份有限公司 Amorphous body of tetracyclic compound
US11077093B2 (en) 2015-01-16 2021-08-03 Chugai Seiyaku Kabushiki Kaisha Combination drug
AR116113A1 (en) 2018-09-04 2021-03-31 Chugai Pharmaceutical Co Ltd METHOD FOR MANUFACTURING A TETRACYCLIC COMPOUND

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU743899B2 (en) 1997-07-18 2002-02-07 Georgetown University Bicyclic metabotropic glutamate receptor ligands
AU1153601A (en) 1999-10-29 2001-05-08 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole NMDA NR2B antagonists

Also Published As

Publication number Publication date
DE60033649D1 (en) 2007-04-12
EP1178988A4 (en) 2004-10-06
CA2372032A1 (en) 2000-11-23
EP1178988A1 (en) 2002-02-13
JP2002544275A (en) 2002-12-24
EP1178988B1 (en) 2007-02-28
US6632822B1 (en) 2003-10-14
WO2000069856A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
ATE355288T1 (en) COMPOUNDS AND THERAPEUTIC METHODS
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
DE60029799D1 (en) COMPOUNDS, PROCESSES AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS, FOR EXAMPLE, DAMAGE TO NERVE OR CANDLE TISSUE
ATE339406T1 (en) CHINAZOLINE COMPOUNDS AS REMEDIES
DE60038183D1 (en) COMPOUNDS AND COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS
ME00513B (en) Azabicycloalkanes as ccr5 modulators
TR199903331T2 (en) Farnesil protein transferase inhibitors.
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
MXPA02006029A (en) Novel lipopeptides as antibacterial agents.
MXPA02006030A (en) Lipopeptides as antibacterial agents.
ATE355374T1 (en) THERAPEUTIC AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AMYLOIDOGENIC DISEASES
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
HK1021699A1 (en) Pentafluorobenzenesulfonamides and analogs.
AU3304400A (en) Tetrahydropyran derivatives and their use as therapeutic agents
IS6558A (en) Mixed disease treatment with vasoconstrictor
YU13301A (en) Muscarinic agonists and antagonists
ES2144054T3 (en) TRI COMPLEXES (PLATINUM).
SE0003476D0 (en) Compounds
TR200103638T2 (en) IL-8 Receptor antagonists
DE69612056D1 (en) TERPEN DERIVATIVES (SARCODICTYINE) AS AN ANTICRECELLENT
MXPA06007007A (en) Proline derivatives used as pharmaceutical active ingredients for the treatment of tumours.
ATE187956T1 (en) SUBSTITUTED CONDENSED AND BRIDGED BICYCLIC COMPOUNDS AS THERAPEUTIC AGENTS
ATE306283T1 (en) BIOTIN DERIVATIVES AND THEIR CONJUGATES WITH CHELATING AGENTS
ATE404550T1 (en) CHEMICAL COMPOUNDS
AU7079300A (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties